Table:
begin	end	state
1	5	non-cytoplasmic
6	33	transmembrane
34	51	cytoplasmic
52	73	transmembrane
74	101	non-cytoplasmic
102	125	transmembrane
126	136	cytoplasmic
137	157	transmembrane
158	169	non-cytoplasmic
170	196	transmembrane
197	215	cytoplasmic
216	239	transmembrane
240	244	non-cytoplasmic
245	263	transmembrane
264	274	cytoplasmic
275	296	transmembrane
297	308	non-cytoplasmic
309	333	transmembrane
334	337	cytoplasmic
338	356	transmembrane
357	361	non-cytoplasmic
362	383	transmembrane
384	402	cytoplasmic
403	425	transmembrane
426	430	non-cytoplasmic

Input:
>WP_086508865.1 NCBI__GCF_002151265.1:WP_086508865.1
MEVFVIMFVSLIVLLMLGVPVAFAMIASSALVLGYTRGFDAIPMEMISQRMLYGVNSFTL
LAIPAFLLIGRLMNSAGISDRVFDIARTMVGHLKGGLGHVNVVASMLFAGMSGSAVADAG
GLGALEIKAMEDDGYPTGFSAAVTASSATIGPIIPPSIPAVIYGALANASIAAIFLASII
PGLIMGLGLMAMVAIISHRRGFPTRARAKFSEFLAALWRGLLPMLTPLIIIVGILSGIFT
PTEASVVALLYCLIIAFLVYRSISFFEFLNILRATAIDTAVLLFIIAGSALYSWVLARYQ
VTSLVADFLLTTVTSPLGVLLLLALFILLIGLFIDSVPALFLLTPLLVPVVTQYGIDPVH
FGVVMIFTLMIGLITPPVGTVLFTIQKITAMPFGGLVREILPFYIPLIIVLLGIILFPSI
VMFLPNLIMN

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server